Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Vivos Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q3 2025
- Shares held
- 658.1K
- −28.6K (−4.2%) vs. Q3 2025
- Total value
- $1.34M
- −$793.2K (−37.3%) vs. Q3 2025
- New holders
- 1
- 6 more added
- Sold out
- 4
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $647.4K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.17M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 304,161 | $617.4K | 0.00% | +212,700+232.6% | Added |
| DRW Securities, LLC | 115,907 | $235.3K | 0.02% | +74,441+179.5% | Added |
| Geode Capital Management, LLC | 56,287 | $114.3K | 0.00% | +2,998+5.6% | Added |
| National Asset Management, Inc. | 43,531 | $88.4K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 40,500 | $82.2K | 0.00% | −500−1.2% | Reduced |
| BlackRock, Inc. | 27,817 | $56.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 24,922 | $50.6K | 0.00% | 00.0% | Unchanged |
| Acorn Wealth Advisors, LLC | 14,776 | $30.0K | 0.01% | +14,776 | New |
| UBS Group AG | 12,677 | $25.7K | 0.00% | +12,575+12,328.4% | Added |
| Northern Trust Corp | 12,511 | $25.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,965 | $6.02K | 0.00% | +171+6.1% | Added |
| Advisor Group Holdings, Inc. | 1,143 | $2.32K | 0.00% | −5,410−82.6% | Reduced |
| Signaturefd, LLC | 547 | $1.11K | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 160 | $325 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 132 | $267 | 0.00% | +15+12.8% | Added |
| Kozak & Associates, Inc. | 49 | $101 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 23 | $47 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7 | $14 | 0.00% | −1,058−99.3% | Reduced |
| Citigroup Inc | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Strategic Wealth Designers | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −39,279−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |